-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
REGENERX BIOPHARMACEUTICALS INC quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q1 2019 to Q1 2023.
- REGENERX BIOPHARMACEUTICALS INC Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Mar 2023 was $32,223.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)